Bacteria, especially symbiotic species in the gastrointestinal tract, have lived with human for long time and are involved in many aspects of host physiology. There is growing evidence that microbiota-gut-brain axis plays an important role in modulating the response to stress in both human and animals. Alterations in the gut microbiota can change the central nervous system function through effects on the endocrine, immune and nervous systems. Recent studies suggest that probiotic treatment may help to maintain resistance against the detrimental effects of stress though the microbiota-gut-brain axis. However, how potentially beneficial bacteria interact with specific immune and neural components, to mediate beneficial effects on behavior remain unclear. Using chronic social defeat stress, a model often used in post-traumatic stress disorder research, we found that administration of Lactobacillus rhamnosus JB-1 beginning 48 hours following chronic social defeat led to persistence of fear memory and social deficits. These effects were associated with changes in gene expression related to emotion and memory in the hippocampus. This was in contrast to previous studies showing that probiotic intervention during social defeat prevents stress induced deficits in social behavior. This indicates that timing of L. rhamnosus treatment in relation to stress exposure has important implications for effects of the bacteria on behavior. In relation to the mechanism of action of L. rhamnosus on behavior, we demonstrate through depletion and adoptive transfer experiments that CD4+CD25+ T cells in mice treated with JB-1 were necessary and sufficient for JB-1 induced anxiolytic and antidepressant-like effects. Evidence also suggested that Ly6Chi monocytes may be a downstream target inhibited by Tregs involved in the behavioral effects of the bacteria. We observed that JB-1 could also reduce the number of activated microglia in the hippocampus, and attenuate hypothalamic-pituitary-adrenal axis reactivity with the integrity of vagus nerve. Crucially we demonstrated that JB-1 induced promotion of peripheral Tregs, reduction in microglia activation in the hippocampus, and attenuation of HPA axis reactivity, were all inhibited following vagotomy indicating that vagus nerve integrity is required to maintain immune and endocrine linkages from gut microbes to the brain. These studies demonstrate prerequisites for beneficial probiotic effects on stress related behaviours including a specific time window in relation to stress exposure, the activation of regulatory immune cells, and undisrupted vagal nerve signalling. These findings highlight the inter-systemic communication of the microbiota-gut-brain axis in the stress response, and might help to unveil more therapeutic opportunities in relation to stress-related mood disorders. / Thesis / Doctor of Philosophy (PhD) / Excessive exposure or dysregulated responses to stress in human and animals induces behavioral changes and the development of mood disorders. The Microbiota-gut-brain axis plays an important role in maintenance of homeostasis. However, crosstalk between the different components of microbiota-gut-brain axis, and how specific microbes can modulate these interactions, remains unclear. Thus, we sought to understand the mechanism of inter-systemic communication linking a specific gut microbe to changes in stress response and behavior. We observed immunoregulation by regulatory T cells were essential in Lactobacillus rhamnosus JB-1 induced anxiolytic and antidepressant-like effects. We also found the integrity of vagus nerve was necessary for JB-1 induced promotion of regulatory T cells and decrease in microglial activation and attenuation of hypothalamic-pituitary-adrenal axis that are associated with the anxiolytic effects of the bacteria. We also identified that the temporal relationship between exposures to stress and the bacteria is important as ingestion of JB-1 directly after chronic social defeat lead to persistence of fear memory and social deficits. This work will help us to understand mechanisms underlying the microbiota-gut-brain axis, which may allow for the development of novel microbe based therapeutic intervention against mood disorders.

The Mediterranean diet (Medi) has been highlighted as the golden diet rich in protective properties associated with cognitive- and emotional health. The foundation of the Medi comprises vegetables, fruits, nuts and seeds, legumes, and extra virgin olive oil. Research has been conducted in both holistic dietary approach and single nutrient approach regarding the impact of nutrition and diet, in this case, the Medi‟s effect on brain health. This review aims to give an up to date overview of the Mediterranean diet, outline some of the diet's abundant nutrients, and discuss studies linking the nutrient's potential effect on depression, cognitive decline, dementia, and brain structure and function. In addition, this review will attempt to assess whether the Medi as a whole or if a single nutrient approach is accountable for the health-promoting findings. Furthermore, the gut-brain axis, and other potential underlying mechanisms involved in the modulation of food- and nutrient intake and their effects on the brain, will be outlined. A diet high in fruit-, vegetable-, polyunsaturated fatty acid-, and monounsaturated fatty acid content has great power for health-maintenance and decreases the risk of suffering cognitive decline, dementia, and potentially depression. More randomized controlled trials are however eagerly awaited to give more substance to previous findings.

Flera miljoner människor världen över är idag drabbade av depression vilket skapar ett stort lidande. Depression leder även många gånger till självmord. Känt är att tarmmikrobiotan är en viktig del i sjukdomsförloppet [MB1] och att kunna karakterisera tarmmikrobiota som är av psykobiotisk karaktär blir därför viktigt i ett behandlande syfte men också för att kunna ställa diagnos mer objektivt. Syftet med den här litteraturstudien är att genom artikelgranskning i PubMed undersöka vad senaste forskningen säger om tarmmikrobiotans roll i tryptofanmetabolismen med efterföljande effekt på depression. Skiljer sig tarmmikrobiotan och tryptofanmetabolismen mellan individer med och utan depression och kan tarmmikrobiotan och tryptofanmetaboliter användas som biomarkörer för att diagnostisera depression? Resultatet visar att tarmmikrobiotan och vissa tryptofanmetaboliter skiljer sig signifikant åt mellan friska individer och individer med depression. Studiens slutsats är att tarmmikrobiota och tryptofans metaboliter skulle kunna användas som biomarkörer för att kunna diagnostisera depression mer objektivt. Dock förekommer flera olika potentiella confounders som bör tas i beaktning. / Several million people worldwide are today affected by depression, which creates a lot of suffering. Depression also often leads to suicide. It is known that the gut microbiota is an important part of the course of the disease and being able to characterize gut microbiota that is of a psychobiotic nature therefore becomes important for a treatment purpose but also to be able to make a diagnosis more objectively. The aim of this literature study is to examine, through article review in PubMed, what the latest research says about the role of gut microbiota in tryptophan metabolism with subsequent effect on depression. Do gut microbiota and tryptophan metabolism differ between individuals with and without depression and can gut microbiota and tryptophan metabolites be used as biomarkers to diagnose depression? The results show that the gut microbiota and certain tryptophan metabolites differ significantly between healthy individuals and individuals with depression. The study's conclusion is that gut microbiota and tryptophan metabolites could be used as biomarkers to diagnose depression more objectively. However, there are several different potential confounders that should be taken into account.